An atherogenic lipid profile with low serum paraoxonase-1 activity during nematode infection in rats

European Journal of Clinical Investigation

Volumn 40, Issue 11, 2010, Pages 984-993

  Farid, Ayman Samir ^a,b   Mido, Shogo ^b   Linh, Bui Khanh ^c   Hayashi, Toshiharu ^c   Horii, Yoichiro ^b  

^a Benha University   (Egypt)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; High fat diet; Lipid metabolism; Nippostrongylus brasiliensis; Oxidized LDL; Paraoxonase 1 reduction

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN RECEPTOR; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; DOWN REGULATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; KUPFFER CELL; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; NEMATODIASIS; NEUTROPHIL; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; UPREGULATION;

AGED; AGED, 80 AND OVER; ANIMALS; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; DIETARY FATS; DISEASE MODELS, ANIMAL; ENERGY INTAKE; HUMANS; LIPIDS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NEMATODE INFECTIONS; NIPPOSTRONGYLUS; RANDOM ALLOCATION; RATS; RATS, WISTAR; STATISTICS AS TOPIC;

EID: 78649397049     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02352.x     Document Type: Article

References (50)

1. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005;69:541-50.
2. James RW. A long and winding road: defining the biological role and clinical importance of paraoxonases. Clin Chem Lab Med 2006;44:1052-9.
3. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med 2005;38:153-63.
4. Mackness B, Mackness M. Anti-inflammatory properties of paraoxonase-1 in atherosclerosis. Adv Exp Med Biol 2010;660:143-51.
5. Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 2009;50(Suppl):S376-81.
6. Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K et al. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 2004;53:297-302.
7. Farid AS, Nakahara K, Murakami N, Hayashi T, Horii Y. Decreased serum paraoxonase-1 activity during intestinal nematode (Nippostrongylus brasiliensis) infection in rats. Am J Trop Med Hyg 2008;78:770-6.
8. Horton J. Human gastrointestinal helminth infections: are they now neglected diseases? Trends Parasitol 2003;19:527-31.
9. Stepek G, Buttle DJ, Duce IR, Behnke JM. Human gastrointestinal nematode infections: are new control methods required? Int J Exp Pathol 2006;87:325-41.
10. Jabbour S, Nishtar S, Prabhakaran D, Chockalingam A, Achutti A, Agrawal A et al. Information and communication technology in cardiovascular disease prevention in developing countries: hype and hope. Report of the International Collaboration on Information Use in Cardiovascular Health Promotion in Developing Countries. Int J Cardiol 2003;92:105-11.
11. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601.
12. Report of the World Health Organization. Active ageing: a policy framework. Aging Male 2002;5:1-37.
13. Ishikawa N, Horii Y, Oinuma T, Suganuma T, Nawa Y. Goblet cell mucins as the selective barrier for the intestinal helminths: T-cell-independent alteration of goblet cell mucins by immunologically 'damaged' Nippostrongylus brasiliensis worms and its significance on the challenge infection with homologous and heterologous parasites. Immunology 1994;81:480-6.
14. Beltowski J, Jamroz-Wisniewska A, Borkowska E, Wójcicka G. Differential effect of antioxidant treatment on plasma and tissue paraoxonase activity in hyperleptinemic rats. Pharmacol Res 2005;51:523-32.
15. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-80.
16. Rideout TC, Yuan Z, Bakovic M, Liu Q, Li RK, Mine Y et al. Guar gum consumption increases hepatic nuclear SREBP2 and LDL receptor expression in pigs fed an atherogenic diet. J Nutr 2007;137:568-72.
17. Lim CS, Vaziri ND. The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. Kidney Int 2004;65:1802-9.
18. Armstrong D, Browne R. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 1994;366:43-58.
19. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-8.
20. Anai M, Funaki M, Ogihara T, Kanda A, Onishi Y, Sakoda H et al. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes 1999;48:158-69.
21. Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev 2007;29:62-76.
22. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581-90.
23. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:473-80.
24. Farid AS, Horii Y. Gastrointestinal nematode infection increases organophosphate toxicity in rats. Toxicol Lett 2008;180:33-7.
25. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996;7:69-76.
26. Feingold KR, Memon RA, Moser AH, Grunfeld C. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 1998;139:307-15.
27. Thomàs-Moyà E, Gianotti M, Proenza AM, Lladó I. Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved. Mol Med 2007;13:203-9.
28. Kumon Y, Suehiro T, Ikeda Y, Hashimoto K. Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1beta and tumor necrosis factor-alpha, but is upregulated by interleukin-6. Life Sci 2003;73:2807-15.
29. Han CY, Chiba T, Campbell JS, Fausto N, Chaisson M, Orasanu G et al. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes. Arterioscler Thromb Vasc Biol 2006;26:1806-13.
30. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006;26:1175-86.
31. Gay J, Fioramonti J, Garcia-Villar R, Bueno L. Development and sequels of intestinal inflammation in nematode-infected rats: role of mast cells and capsaicin-sensitive afferents. Neuroimmunomodulation 2000;8:171-8.
32. Halpern MD, Holubec H, Dominguez JA, Meza YG, Williams CS, Ruth MC et al. Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2003;284:G695-702.
33. Horie Y, Wolf R, Anderson DC, Granger DN. Nitric oxide modulates gut ischemia-reperfusion-induced P-selectin expression in murine liver. Am J Physiol 1998;275:H520-6.
34. Smedsrod B, De Bleser PJ, Braet F, Lovisetti P, Vanderkerken K, Wisse E et al. Cell biology of liver endothelial and Kupffer cells. Gut 1994;35:1509-16.
35. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007;35:757-66.
36. Ovington KS. Nippostrongylus brasiliensis: physiological and metabolic responses of rats to primary infection. Exp Parasitol 1987;63:10-20.
37. Hasham SN, Pillarisetti S. Vascular lipases, inflammation and atherosclerosis. Clin Chim Acta 2006;372:179-83.
38. Grunfeld C, Gulli R, Moser AH, Gavin LA, Feingold KR. Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res 1989;30:579-85.
39. Feingold KR, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 1987;80:184-90.
40. Jovinge S, Hamsten A, Tornvall P, Proudler A, Bavenholm P, Ericsson CG et al. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 1998;47:113-8.
41. Feingold KR, Pollock AS, Moser AH, Shigenaga JK, Grunfeld C. Discordant regulation of proteins of cholesterol metabolism during the acute phase response. J Lipid Res 1995;36:1474-82.
42. De Vasconcelos PR, Kettlewell MG, Gibbons GF, Williamson DH. Increased rates of hepatic cholesterogenesis and fatty acid synthesis in septic rats in vivo: evidence for the possible involvement of insulin. Clin Sci (Lond) 1989;76:205-11.
43. Memon RA, Grunfeld C, Moser AH, Feingold KR. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 1993;132:2246-53.
44. Hardardottir I, Moser AH, Memon R, Grunfeld C, Feingold KR. Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res 1994;13:161-6.
45. Van Lenten BJ, Hama SY, De Beer FC, Stafforini DM, McIntyre TM, Prescott SM et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995;96:2758-67.
46. Smith NC, Bryant C. Free radical generation during primary infections with Nippostrongylus brasiliensis. Parasite Immunol 1989;11:147-60.
47. Esteve E, Ricart W, Fernandez-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005;24:16-31.
48. Woo KS, Chook P, Raitakari OT, McQuillan B, Feng JZ, Celermajer DS. Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19:2487-93.
49. Morre SA, Stooker W, Lagrand WK, Van Den Brule AJ, Niessen HW. Microorganisms in the aetiology of atherosclerosis. J Clin Pathol 2000;53:647-54.
50. Russell JC. Evaluating micro- and macro-vascular disease, the end stage of atherosclerosis, in rat models. Methods Mol Biol 2009;573:17-44.